TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive Virology Contract Phaseout To Cut $5 Million In FY 1980; Bigger reduction Coming In 1982 July 27, 1979
TCL Archive PET Three Months After Therapy Provides Early Warning Of Need For Intervention November 30, 2007
TCL Archive In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds November 28, 1975
TCL Archive DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money August 31, 1979
